VANCOUVER As part of the federal government’s investment in domestic vaccine capability, a Vancouver company is taking their $25.1 million allotment to build a massive manufacturing facility in the Lower Mainland. South Vancouver-based Precision Nanosystems is building a $50.2 million biomanufacturing centre that could produce up to 240 million doses of vaccine every year in the 40,000 square foot facility. It s still assessing possible locations. Its estimated completion date is March 2023, but the company’s CEO says the investment is important on a number of levels. It s an investment in pandemic preparedness, an investment in the future, an investment in these critical technologies that are really the technologies of the future,” said James Taylor in a Zoom interview. “What we’re focussed on is the medium- to long-term pandemic responsiveness as well as developing capabilities and capacity around genetic medicine itself, so our facility will be able to ut
Melissa Couto Zuber January 22, 2021 - 11:40 AM
When drug companies like Pfizer and Moderna learned to successfully incorporate messenger RNA technology into a COVID-19 vaccine, experts say they likely opened the door to a significant shift in the future of immunization.
The milestone in vaccine development was met with enthusiasm from most, but the seemingly swift pace and novel approach is causing hesitancy in others.
Experts say the new technique shouldn t dissuade people from getting the vaccine. While the mRNA method is new to inoculations, the actual technology has been around for decades.
The difference now, they say, is scientists have ironed out the kinks to make a useful product.
When drug companies like Pfizer and Moderna learned to successfully incorporate messenger RNA technology into a COVID-19 vaccine, experts say they likely opened the door to a significant shift in the future of immunization. The milestone in vaccine development was met with enthusiasm from most, but the seemingly swift pace and novel approach is causing hesitancy in others. Experts say the new technique shouldn t dissuade people from getting the vaccine. While the mRNA method is new to inoculations, the actual technology has been around for decades. The difference now, they say, is scientists have ironed out the kinks to make a useful product.